72730-202 : Truseltiq 75 mg Oral Capsule
| NDC: | 72730-202 |
| Labeler: | Qed Therapeutics, Inc. |
| Product Type: | Human Prescription Drug |
| Drug Name: |  Truseltiq |
| Dosage Form: | Oral Capsule |
| Application #: | NDA214622 |
| Rev. Date: |
NDC Package Codes:
- 72730-202-01: 1 BLISTER PACK IN 1 CARTON (72730‑202‑01) > 63 CAPSULE IN 1 BLISTER PACK
Active Ingredients:
- Infigratinib
Dosage Strength:
- 75 mg
Related Products:
Based on records with the same trade name.- 72730-101 Truseltiq 125 mg Oral Capsule by Qed Therapeutics, Inc.
- 72730-111 Truseltiq 100 mg Oral Capsule by Qed Therapeutics, Inc.
- 72730-506 Truseltiq 50 mg Oral Capsule by Qed Therapeutics, Inc.
NDC QR Code
Scan the QR code below to easily reference this data in the future:
< Prev: 72730-111Next: 72730-506 >
Note: The RxChat NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.